How do I handle advertising for medical devices in China?

Date:

Share post:






How Do I Handle Advertising for Medical Devices in China?


How Do I Handle Advertising for Medical Devices in China?

Advertising medical devices in China is one of the most rigorously regulated advertising activities a foreign company can undertake. China classifies medical devices into three risk categories, each subject to progressively stricter advertising requirements. The regulatory framework — governed primarily by the Advertising Law, the Regulations on the Supervision and Administration of Medical Devices, and the Measures for the Administration of Medical Device Advertising — imposes pre-approval requirements, content restrictions, channel limitations, and mandatory disclosures that far exceed those in most Western markets.

For foreign medical device manufacturers and distributors, non-compliance can result in severe penalties including advertising bans, product seizure, and criminal liability. This FAQ provides a comprehensive guide to advertising medical devices in China, covering classification, pre-approval processes, permitted and prohibited content, channel restrictions, digital marketing considerations, and practical compliance strategies.

Medical Device Classification and Its Impact on Advertising

China’s National Medical Products Administration (NMPA) classifies medical devices into three categories based on risk level. The advertising rules for each category differ significantly:

Class Risk Level Examples Advertising Requirements
Class I Low risk Surgical masks, bandages, tongue depressors, examination gloves Must comply with general advertising law; no pre-approval required but content must be truthful and not misleading
Class II Medium risk Blood pressure monitors,血糖仪 (blood glucose meters), diagnostic ultrasound equipment, contact lenses Pre-approval of advertising content required; must display approval number
Class III High risk Implantable pacemakers, coronary stents, artificial joints, ventilators, HIV test kits Pre-approval required; advertising restricted to professional medical channels; no consumer-facing advertising allowed
Key Point: The classification of your medical device determines not just what you can say in advertising, but where and to whom you can say it. Class III devices are effectively prohibited from advertising to the general public, while Class I devices can be advertised with relatively few restrictions provided the content is truthful and compliant.

The Advertising Pre-Approval Process

For Class II and Class III medical devices, all advertising content must receive pre-approval from SAMR (or its delegated local bureau) before publication. The process is as follows:

Step 1: Determine the Responsible Review Authority

Advertising for medical devices is reviewed by the local SAMR bureau where the advertiser’s legal entity is registered. For imported medical devices, the review is typically handled by the SAMR bureau in the province where the Chinese agent or distributor is registered. Foreign manufacturers without a Chinese entity must appoint a local agent to submit the application.

Step 2: Prepare the Application Dossier

The application must include the following documents:

  • Medical Device Registration Certificate (医疗器械注册证) — issued by NMPA, proving the device is legally registered for sale in China
  • Medical Device Production License (医疗器械生产许可证) — for domestically manufactured devices, or manufacturing authorization documents for imported devices
  • Business license of the advertising applicant
  • Advertising content proofs — the complete advertisement in final form, including copy, images, video, or audio files
  • Instructions for Use (产品说明书) — the approved user manual that accompanies the device, as filed with NMPA
  • Claim substantiation materials — clinical trial data, scientific literature, or technical standards supporting any claims made in the advertisement
  • Authorization letter if the application is submitted by an agent on behalf of the manufacturer

Step 3: Submit for Technical Review

The SAMR bureau conducts a substantive review of the advertising content. The review examines compliance with:

  • The specific content restrictions for medical device advertising (see below)
  • General provisions of the Advertising Law
  • Accuracy of claims relative to the device’s approved indications and Instructions for Use
  • Appropriateness of the advertising medium for the device class

The statutory review period is 10 working days, but in practice, reviews can take 20 to 30 working days, especially for complex devices or advertising content that requires clarification.

Step 4: Receive Approval and Display Approval Number

If approved, the advertisement receives a unique approval number in the format “Jian Guang Shen Zi [Year] XXXX.” This number must be prominently displayed in the advertisement. The approval is generally valid for one year (matching the validity period of the Medical Device Registration Certificate) or for the duration of a specific campaign, whichever is shorter.

Important: The pre-approval is specific to the approved content. Making any substantive change to the advertisement — including changing images, modifying claims, or altering the format — requires re-approval. Even minor wording changes that affect the meaning of a claim trigger the re-approval requirement.

Prohibited Content in Medical Device Advertising

The Measures for the Administration of Medical Device Advertising specify the following content prohibitions for all medical device advertising:

  • Disease cure or prevention claims: No advertisement may claim that the device can cure or prevent a disease, unless the device’s approved indications specifically include such claims.
  • Comparative superiority claims: No advertisement may claim that the device is superior or comparable to other devices, pharmaceuticals, or treatments, unless supported by rigorous clinical evidence.
  • Testimonials and endorsements: No user testimonials, patient endorsements, or celebrity endorsements are permitted for Class II and Class III medical devices. Even for Class I devices, testimonials are subject to the general restrictions discussed in the testimonials FAQ.
  • Medical professional endorsements: Using images or endorsements from doctors, hospitals, or medical institutions is prohibited unless specifically approved.
  • Guarantees of safety or efficacy: No advertisement may guarantee that the device is completely safe or 100% effective. Any safety or efficacy claims must be qualified with the risks and limitations stated in the approved Instructions for Use.
  • Incomplete risk information: All advertisements must include a balance of benefits and risks. Emphasizing benefits while minimizing or omitting risks is prohibited.
  • Misleading technical specifications: Technical specifications, performance metrics, and operational parameters must match exactly what is stated in the approved product registration documentation.
  • Fear-based advertising: Exploiting fear, anxiety, or health concerns to promote a medical device is prohibited.

Channel Restrictions by Device Class

Beyond content restrictions, China imposes channel-specific limitations on medical device advertising:

Class III Devices

Advertising for Class III medical devices is generally restricted to professional medical channels only. This includes:

  • Medical and healthcare professional journals
  • Medical conferences and trade exhibitions
  • Professional detailing materials distributed to healthcare providers
  • Hospital purchasing portals and medical procurement platforms

Class III devices may not be advertised through mass media channels including television, radio, outdoor advertising, general-circulation newspapers, or consumer-facing digital platforms.

Class II Devices

Class II medical devices may be advertised through a broader range of channels, but with restrictions:

  • Consumer-facing advertising is permitted for Class II devices that are intended for home use (e.g., blood pressure monitors, blood glucose meters)
  • Advertising must include the mandatory warning: “Please read the product manual carefully before use”
  • Advertisements on e-commerce platforms must link to or display the product’s medical device registration certificate
  • Broadcast advertisements must include the audio warning “Please use under the guidance of a physician or in accordance with the product manual”

Class I Devices

Class I devices face the fewest channel restrictions but must still comply with general advertising law prohibitions against false or misleading content. However, the trend in enforcement is toward more restrictive interpretation, and some local SAMR bureaus apply Class II standards to Class I devices as a precautionary measure.

Digital Marketing and E-Commerce Considerations

Digital marketing of medical devices in China is subject to the same substantive rules as traditional advertising, with additional requirements specific to online channels:

  • E-commerce product listings: Product listings for medical devices on platforms like Tmall and JD.com are treated as advertising and must comply with all pre-approval requirements. The listing must display the advertising approval number and reference the product’s Medical Device Registration Certificate.
  • Search engine advertising: Paid search advertisements for medical devices must include the medical device registration information and advertising approval number. Search engines like Baidu require verification of these credentials before allowing medical device ads to run.
  • Social media and KOL marketing: Social media posts and influencer content that promote medical devices are subject to the same rules as any other advertising. KOLs must not make claims about medical devices that have not been pre-approved. In practice, many brands avoid KOL marketing for Class II and III medical devices due to the high compliance risk.
  • WeChat official accounts: Brand-owned WeChat official accounts that publish medical device promotional content must ensure that content has been pre-approved if it falls into the Class II or III categories. Educational content about the condition treated by the device is generally permissible, but promotional content requires pre-approval.
  • Telemedicine and remote consultation platforms: Platforms that facilitate telemedicine consultations may not use those consultations as an opportunity to market medical devices to patients without compliance with advertising regulations.

Consequences of Non-Compliance

Violations of medical device advertising regulations can result in severe penalties:

Violation Penalty Legal Basis
Advertising without pre-approval Fine of RMB 50,000 to RMB 500,000; order to cease advertising Advertising Law, Article 58
False or misleading content Fine of 3x advertising spend (min RMB 200,000); advertising ban for 1-3 years Advertising Law, Article 55
Unauthorized testimonials or endorsements Fine of RMB 100,000 to RMB 1,000,000 Advertising Law, Article 58
Advertising Class III device to consumers Fine of RMB 50,000 to RMB 300,000; product recall may be ordered Medical Device Supervision Regulations
Causing personal injury through false advertising Criminal liability; fines up to 5x illegal income; possible imprisonment Criminal Law, Article 222

Practical Compliance Strategy for Foreign Companies

Foreign medical device companies advertising in China should implement a comprehensive compliance strategy covering the following areas:

  • Classification review: Before any advertising activity, confirm the correct NMPA classification of each device. Classification determines the applicable advertising rules. If there is ambiguity, seek a formal classification determination from NMPA or engage a regulatory consultant.
  • Advertising pre-approval workflow: Establish a systematic workflow for obtaining advertising pre-approval. This includes maintaining a library of approved advertising content, tracking approval expiry dates, and managing renewal timelines. The lead time for pre-approval should be factored into all marketing campaign planning.
  • Content localization: Ensure that all advertising content intended for the Chinese market is developed specifically for China, not adapted from content used in other markets. Claims that are perfectly legal in the United States, Europe, or Japan may violate Chinese regulations. Work with a local regulatory consultant to review all content before submission.
  • Channel selection: Select advertising channels that are appropriate for the device class. For Class III devices, restrict advertising to professional channels. For Class II home-use devices, ensure that consumer-facing advertising includes all mandatory warnings and disclosures.
  • KOL management: If using KOLs for medical device promotion, implement strict content controls. Provide pre-approved scripts and monitor all content before publication. Consider contractual provisions that hold the KOL responsible for compliance violations resulting from unscripted content.
  • Training: Train all marketing and sales staff who work on medical device advertising on the specific requirements of Chinese regulations. Annual refresher training is recommended as regulations evolve.
  • Audit program: Conduct regular audits of all published medical device advertising content to identify and correct any compliance issues. Audits should cover both company-published content and content published by distributors, agents, and channel partners.
  • Regulatory monitoring: Subscribe to NMPA and SAMR regulatory updates affecting medical device advertising. China’s medical device regulatory framework is in active development, and new requirements are introduced frequently.

Key Regulations to Reference

  • Advertising Law of the People’s Republic of China (中华人民共和国广告法) — Articles 16, 46 on medical device advertising
  • Regulations on the Supervision and Administration of Medical Devices (医疗器械监督管理条例) — Articles 60-64 on advertising
  • Measures for the Administration of Medical Device Advertising (医疗器械广告审查发布标准)
  • Administrative Measures for Medical Device Registration and Filing (医疗器械注册与备案管理办法)
  • Interim Measures for the Administration of Internet Advertising (互联网广告管理暂行办法) — for digital marketing compliance
  • Classification Rules for Medical Devices (医疗器械分类规则) — for determining device class

Frequently Asked Questions

What is the difference between medical device advertising and medical device information?

The distinction is important. Advertising is defined as any commercial promotion that aims to increase sales of a medical device. Medical device information — such as the Instructions for Use, technical documentation provided to healthcare professionals, or mandatory regulatory communications — is not considered advertising. However, promotional materials disguised as information are treated as advertising. The key test is whether the primary purpose is commercial promotion or informational communication.

Can I advertise a medical device that is not yet registered in China?

No. A medical device must have a valid NMPA registration certificate before it can be advertised in China. Advertising an unregistered device is a serious violation that can result in product seizure, fines, and criminal liability. Even educational or informational content about an unregistered device can be treated as illegal advertising if it has a promotional purpose.

Are software-based medical devices (SaMD) subject to the same advertising rules?

Yes. Software as a Medical Device (SaMD) is classified by NMPA into Class II or III and is subject to the same advertising regulations as hardware medical devices. The pre-approval requirement applies to advertising for SaMD, and the content must accurately reflect the indications for use stated in the software’s registration certificate.

Can I use the CE marking or FDA approval in Chinese medical device advertising?

Foreign regulatory approvals (CE, FDA, PMDA, etc.) may be referenced in Chinese medical device advertising only if the information is accurate and not misleading. However, the advertising must primarily reference the Chinese NMPA registration. Implied or explicit claims that foreign approval is equivalent to or superior to NMPA approval are prohibited. It is advisable to include a statement clarifying that NMPA approval is the controlling regulatory authorization for the Chinese market.


Related articles

Do I Need a China Agent for Product Certification Applications?

Do I need a China agent for product certification applications? body { font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, sans-serif;

What Products Require CCC Certification in China?

What Products Require CCC Certification in China? China Compulsory Certification (中国强制性产品认证, CCC/3C认证, Zhōngguó qiángzhìxìng chǎnpǐn rènzhèng / sān rè

How to Label Products for the China Market: GB Labeling Standards Guide

How to Label Products for the China Market: GB Labeling Standards Guide Every product sold in China must comply with the GB ( 国家标准, guójiā biāozhǔn )

Understanding China’s Multi-Layered Data Regulatory Structure

Understanding China's Multi-Layered Data Regulatory Structure Foreign companies navigating China's data compliance requirements must interface with a